Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats.
D000818:Animals; D001058:Apomorphine / Q000378:metabolism; D001971:Bromocriptine / Q000494:pharmacology; D002230:Carbidopa / Q000494:pharmacology; D003342:Corpus Striatum / Q000187:drug effects; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D006220:Haloperidol / Q000494:pharmacology*; D007980:Levodopa / Q000494:pharmacology; D008297:Male; D011869:Radioligand Assay; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects*; D011955:Receptors, Drug / Q000378:metabolism; D013134:Spiperone / Q000378:metabolism
D011954:Receptors, Dopamine; D011955:Receptors, Drug; D001971:Bromocriptine; D007980:Levodopa; D013134:Spiperone; D006220:Haloperidol; D002230:Carbidopa; D001058:Apomorphine